From GlobeNewswire:

The REPOSE study by Axogen, Inc. compared neurectomy with Axoguard Nerve Cap to standard neurectomy. The study found that Axoguard Nerve Cap demonstrated statistical superiority in reducing total pain compared to the standard treatment. The study also found that the addition of Axoguard Nerve Cap to neurectomy was a better option for managing symptomatic neuroma pain. Axogen’s products are focused on peripheral nerve regeneration and repair, and the company is hopeful that these positive results will lead to increased adoption of Axoguard Nerve Cap for patients with peripheral nerve injuries.



Read more: Axogen, Inc. Announces Positive Topline Results from